RICHARD HAIG: Open Payments
NPI 1164196002 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 61 payments from 9 companies in 2025. Trend: 2023 $2,267 · 2024 $797 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $206 |
| Neurocrine BioSciences, Inc. | 4 | $191 |
| E.R. Squibb & Sons, L.L.C. | 7 | $180 |
| Alkermes, Inc. | 7 | $117 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Noven Therapeutics, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, COBENFY, Auvelity, ARISTADA, SPRAVATO, LYBALVI.
Industry payments across FL — which companies pay providers there.
